SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH M impact

Chugai Pharmaceutical Nine-Month Revenue Rises 17.2%, Profit 21.6%

Revenue was JPY 1,068.1 billion for the nine months ended September 30, 2026. Operating profit rose 21.6% to JPY 522.6 billion, and net income increased 22.8% to JPY 375.3 billion. The fiscal 2026 outlook was unchanged.

4519
SquawkNews Desk

Related stories

Hotman Reports Interim Loss and Forecasts Full-Year Profit Hotman reported a standalone interim net loss, compared with a loss in the prior-year period. It forecasts full-year profit growth of 3.7%. M impact | EQUITY | Oct 30, 2026, 02:00 AM UTC Hotman Reports Interim Ordinary Loss, Forecasts Full-Year Profit Hotman reported an ordinary loss for the interim period, compared with an ordinary loss in the prior-year period. It forecasts full-year ordinary profit, up 6.5%. M impact | EQUITY | Oct 30, 2026, 02:00 AM UTC Asian session market picture: S&P 500 -1.06%, Nasdaq 100 -2.35%; USD/JPY -0.13%, WTI +2.27%, 1810 leads volume Asian session market picture. US index futures: S and P futures is down 1.06 percent, Nasdaq futures is down 2.35 percent, Dow futures is down 0.26 percent and Russell futures is d M impact | EQUITY | Oct 30, 2026, 02:00 AM UTC Holley Performance Brands Acquires SXTH Element Holley Performance Brands acquired SXTH Element, expanding its modern truck and off-road portfolio in Toyota truck and SUV performance. M impact | EQUITY | Oct 30, 2026, 02:00 AM UTC Theta Gold Mines Draws First US$37 Million Under US$90 Million Bond The company says the drawdown followed an US$18.6 million equity raising. L impact | EQUITY | Oct 30, 2026, 01:59 AM UTC Shengyi Technology shares fall 8.7% as Jefferies cuts target Shengyi Technology shares fell 8.7% to 85.9 yuan after opening down 4.9%, while Jefferies lowered its price target. M impact | EQUITY | Oct 30, 2026, 01:58 AM UTC